BioAdaptives, Inc. (BDPT) News
Follow BioAdaptives, Inc. (BDPT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
UFC Hall of Famer and MyndSystem™ brand ambassador shares how the daytime formula fits into his preparation for live broadcasts, commentary, and podcasting.LAS VEGAS, NV / / September 23, 2026 / BioAdaptives, Inc. OTC:BD
EQUITY | Sep 23, 2026, 02:21 PM UTC
L
BDPT - BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
BDPT - BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
NEWS | Sep 23, 2026, 02:15 PM UTC
M
BioAdaptives confirms first orders for XcellaraHeart, details debt and share progress
BioAdaptives says initial XcellaraHeart orders ship next week and mark the commercial launch of its Xcellara cellular wellness platform. It targets XcellaraResilience for October and says it has retired major convertible
EQUITY | Sep 03, 2026, 03:15 PM UTC
L
BioAdaptives confirms first commercial orders for XcellaraHeart
BioAdaptives says it has confirmed its first commercial orders of XcellaraHeart, and it provided an update on capital restructuring progress.
EQUITY | Sep 03, 2026, 03:15 PM UTC
M
BioAdaptives CEO cancels shares; company updates capital restructure
BioAdaptives, Inc. announces the cancellation of the CEO’s shares and provides a capital restructure update for BDPT, according to TradeXchange Newsdesk.
MNA | Aug 13, 2026, 12:35 PM UTC
L
BDPT - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal - Click F
BDPT - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
EQUITY | Aug 12, 2026, 11:30 AM UTC
M
BioAdaptives Opens XcellaraHeart Ordering
BioAdaptives starts commercial sales of XcellaraHeart formula
EQUITY | Aug 03, 2026, 12:00 PM UTC
H
BioAdaptives Retires Largest Convertible Debt
BioAdaptives eliminates major debt overhang
EQUITY | Jul 30, 2026, 12:30 PM UTC
M
BDPT Expands E-Commerce Footprint
BDPT expands e-commerce reach
EQUITY | Jul 29, 2026, 05:15 PM UTC